OSR Holdings, Inc. (NASDAQ:OSRH) Financings

OSR Holdings, Inc.

Financings

RaiseDate
Strategic investment of common stock
Announced: up to US$15M · US$10 a share
Buyers: BCME (may be required to purchase up to $15 million of OSRH common stock at $10.00 per share)
Insiders: BCME, the company's largest shareholder, would be the purchaser under the put option; the agreement is a related party transaction approved by the Board including independent directors.
Apr 29, 2026
Convertible promissory note
Closed: US$555,555 raised
Buyers: White Lion GBM Innovation Fund
Use of proceeds: Near-term liquidity for general corporate purposes and continued execution of strategic priorities
Apr 9, 2026
Private placement of oSRT security tokens
Announced: up to US$50M
Buyers: BCM Europe AG (anticipated participation, subscribing with BTC or USDT rather than TAC)
Use of proceeds: Part of a path toward building a $100 million Bitcoin and USDT reserve on the balance sheet
Jul 8, 2025
Common stock
Announced: up to US$80M
Buyers: White Lion GBM Innovation Fund (up to $80 million in common stock over time, at OSR's option)
Use of proceeds: Advance its Vaximm immunotherapy platform (GBM vaccine VXM01) and other innovative healthcare solutions
Apr 3, 2025

Read by 6ix AI from the company's releases